Combination of gemcitabine and Ad5/3-Δ24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer

A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

Fadlo R. Khuri, John Nemunaitis, Ian Ganly et al. · Nature Medicine · 2000 · 1.1K citations

Medicine, Oncology, Chemotherapy +8

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

Carla Heise, Adam Sampson-Johannes, Angelica Williams et al. · Nature Medicine · 1997 · 947 citations

Medicine, Oncology, Pharmacology +13

CD46 is a cellular receptor for group B adenoviruses

Anuj Gaggar, Dmitry M. Shayakhmetov, André Lieber · Nature Medicine · 2003 · 788 citations

Life Sciences, Cell Biology, Molecular Biology +12

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo

Juàn Fueyo, Candelaria Gomez‐Manzano, Ramón Alemany et al. · Oncogene · 2000 · 772 citations

Medicine, Molecular Biology, Oncology +16

Gemcitabine: metabolism, mechanisms of action, and self-potentiation.

William Plunkett, Peng Huang, Yi-Zheng Xu et al. · PubMed · 1995 · 756 citations

Life Sciences, Pharmacokinetics, Pharmacology +6